Key Metrics
CiteScore 

12
Impact Factor 

10 - 15
SJR 

Q1Neurology (clinical)

SNIP 

1.76
Recommended pre-submission checks
Powered by 

Topics Covered on Translational Neurodegeneration
Translational Neurodegeneration Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | BMC |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | EUR 2490 | USD 2890 | GBP 2090 |
| Publication Time | 10 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC0 |
| OA statement | Visit website |
View less
Planning to publish in Translational Neurodegeneration ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Translational Neurodegeneration
Mesenchymal stromal cells and neuroinflammation: a multimodal approach to neuroprotection and future therapeutic horizons
- 18 May 2026
- Translational Neurodegeneration
Calbindin-D28k deficiency mediates tau-driven hippocampal hyperexcitement and cognitive impairment
- 12 May 2026
- Translational Neurodegeneration
The emerging role and therapeutic targeting of autophagy-lysosome pathway in the pathogenesis of Parkinson's disease.
- 7 May 2026
- Translational neurodegeneration
A new dawn for Parkinson's disease: commentary on the emergence of stem cell-based therapies.
- 29 Apr 2026
- Translational neurodegeneration
The Drp1-CoQ10-Coa6-ETC axis represents a therapeutic potential for working memory impairment caused by neuronal mitochondrial dysfunction.
- 27 Apr 2026
- Translational neurodegeneration
N-terminally acetylated Met11-Tau: a new pathological truncated Tau species with functional relevance in Alzheimer's disease.
- 27 Apr 2026
- Translational neurodegeneration
Mesenchymal stromal cells and neuroinflammation: a multimodal approach to neuroprotection and future therapeutic horizons
- 18 May 2026
- Translational Neurodegeneration
Calbindin-D28k deficiency mediates tau-driven hippocampal hyperexcitement and cognitive impairment
- 12 May 2026
- Translational Neurodegeneration
The emerging role and therapeutic targeting of autophagy-lysosome pathway in the pathogenesis of Parkinson's disease.
- 7 May 2026
- Translational neurodegeneration
A new dawn for Parkinson's disease: commentary on the emergence of stem cell-based therapies.
- 29 Apr 2026
- Translational neurodegeneration
The Drp1-CoQ10-Coa6-ETC axis represents a therapeutic potential for working memory impairment caused by neuronal mitochondrial dysfunction.
- 27 Apr 2026
- Translational neurodegeneration
N-terminally acetylated Met11-Tau: a new pathological truncated Tau species with functional relevance in Alzheimer's disease.
- 27 Apr 2026
- Translational neurodegeneration